Sign In to Request a Protocol
Sign In to Request a Protocol

CJC-1295 DAC (5 mg) + Ipamorelin (5 mg) Stack

  • Table of Contents

CJC-1295 DAC Research Chart

CJC-1295 DAC is studied in research settings for its biological characteristics and potential applications. This information is provided for research and educational reference only.

  • CJC-1295 DAC: For specific research details, additional information, or availability, please contact us on Telegram.
  • Ipamorelin: For additional research information or availability, please contact us on Telegram.
  • Research Details: This information is provided for general educational and research reference only.
  • Storage: Please follow the provided label or packaging instructions for proper storage. For additional storage details, please contact us on Telegram.
This research information is provided for general educational and research reference only. CJC-1295 DAC and Ipamorelin are included here as part of a general research overview. This content is not intended as medical advice, clinical guidance, or usage instruction. For additional information, please contact us on Telegram.
  • Research Information Guide

Educational overview for stacked GH secretagogue research information.

CJC-1295 DAC (5 mg Vial) — Research Overview

Research Information: General information related to CJC-1295 DAC is provided for educational and research reference only.
PhaseWeekly Daily Blend (mg)Volume (mL)Frequency
Standard1000 mcg (1.0 mg)40 units (0.40 mL)Once weekly
Aggressive2000 mcg (2.0 mg)80 units (0.80 mL)Once weekly

Note: Research information may vary depending on study design and available documentation.

CJC-1295 DAC Research Information Steps

  • 1. Review available documentation for general research information.
  • 2. For additional research details, please contact us on Telegram.
  • 3. For further information, please contact us directly.
  • 4. This content is provided for general educational and research reference only.

Ipamorelin (5 mg Vial) — Subcutaneous, Once Daily

Reconstitution: 3.0 mL bacteriostatic water → 1.67 mg/mL (1666.7 mcg/mL) → 16.67 mcg per unit

PhaseDaily Blend (mg)Volume (mL)Frequency
Weeks 1–2 (Initiation)100 mcg (0.1 mg)6 units (0.06 mL)Once daily
Weeks 3–4 (Titration)150 mcg (0.15 mg)9 units (0.09 mL)Once daily
Weeks 5+ (Maintenance)200 mcg (0.2 mg)12 units (0.12 mL)Once daily
Aggressive (Optional)300 mcg (0.3 mg)18 units (0.18 mL)Once daily or split 2×/day

For ≤10-unit (≤0.10 mL) administrations, consider 30- or 50-unit insulin syringes for improved readability.

Ipamorelin Reconstitution Steps

  • 1. This section includes general information about Ipamorelin for educational reference.
  • 3. Any preparation or handling details should be confirmed directly through Telegram support.
  • 4. This information is not intended as medical advice, or usage instruction.

Combined Stack Schedule — Standard Approach

WeekCJC-1295 DAC (Weekly)Ipamorelin (Daily)
Weeks 1–21000 mcg (40 units) once weekly100 mcg (6 units) once daily
Weeks 3–41000 mcg (40 units) once weekly150 mcg (9 units) once daily
Weeks 5–121000 mcg (40 units) once weekly200 mcg (12 units) once daily
Timing: CJC-1295 DAC is typically administered on a fixed day each week. Ipamorelin is commonly administered before bed to coincide with natural nocturnal GH pulses.

Ipamorelin Reconstitution Steps

  • 1. This section includes general information about Ipamorelin for educational reference.
  • 3. Any preparation or handling details should be confirmed directly through Telegram support.
  • 4. This information is not intended as medical advice, or usage instruction.

Important: This guide is for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment.

  • Research Details

This section provides general research information for educational and research reference only. For specific details, additional information, or availability, please contact us on Telegram.

  • CJC-1295 DAC Vials (5 mg each):
  • 8 weeks: 64 syringes
  • 12 weeks: 96 syringes
  • 16 weeks: 128 syringes
  • Ipamorelin Vials (5 mg each):
  • 8 weeks (56 days at ~200 mcg/day) → 3 vials
  • 12 weeks (84 days) → 4 vials
  • 16 weeks (112 days) → 5 vials
  • Insulin Syringes (U-100):
  • Per week: 1 (CJC) + 7 (Ipamorelin) = 8 syringes
  • 8 weeks: 64 syringes
  • 12 weeks: 96 syringes
  • 16 weeks: 128 syringes

For Ipamorelin ≤10 units, 30- or 50-unit syringes improve accuracy.

  • Bacteriostatic Water (10 mL bottles):
  • 8 weeks: CJC (2 × 2 mL = 4 mL) + Ipam (3 × 3 mL = 9 mL) = 13 mL → 2 × 10 mL bottles
  • 12 weeks: CJC (3 × 2 mL = 6 mL) + Ipam (4 × 3 mL = 12 mL) = 18 mL → 2 × 10 mL bottles
  • 16 weeks: CJC (4 × 2 mL = 8 mL) + Ipam (5 × 3 mL = 15 mL) = 23 mL → 3 × 10 mL bottles
  • Alcohol Swabs:
  • Per week: ~16 swabs (2/day for Ipamorelin + 2 for CJC weekly)
  • 8 weeks: 128 swabs → 2 × 100-count boxes
  • 12 weeks: 192 swabs → 2 × 100-count boxes
  • 16 weeks: 256 swabs → 3 × 100-count boxes
  • Protocol Overview

Concise summary of general research information for educational and research reference only.

  • Goal: Provide organized research information for visitors.
  • Schedule: For additional details, please contact us on Telegram.
  • CJC-1295 DAC: Research details are available upon request.
  • Ipamorelin: For additional research information, please contact us on Telegram.
  • Storage: Please follow the provided label or packaging instructions.
  • Research Information

General research information provided for educational and research reference only.

  • CJC-1295 DAC: For specific research details, please contact us on Telegram.
  • Ipamorelin: For availability or additional research information, please contact us on Telegram.
  • Timing: Research-related information is available upon request.
  • Research Support: For additional information, please contact us directly.
  • Important: This content is not intended as medical advice, clinical guidance, or research usage instruction.
  • Storage Instructions
Proper storage information is provided for general educational and research reference only.
  • Label Information: Please follow the provided label or packaging instructions for proper storage.
  • Research Details: For storage-related or handling-related information, please contact us on Telegram.
  • Handling Note: Keep research information and handling details consistent with the provided documentation.
  • Important: This content is not intended as medical advice, research guidance, clinical guidance, or general usage information.
  • Important Notes

Practical research information for general educational and research reference only.

  • Research Details: For specific research details, please contact us on Telegram.
  • Additional Information: For handling-related information, please contact us directly.
  • Availability: General availability information is available upon request.
  • Important: This content is not intended as medical advice, research guidance, clinical guidance, or general usage information.
  • Support: For additional information, please contact us on Telegram.
  • How This Works

CJC-1295 DAC and Ipamorelin information is provided for general educational and research reference only. This section is intended to give visitors a simple overview of the research field without providing medical advice, clinical guidance, research guidance, or general usage information. For additional details or information, please contact us on Telegram.

  • Potential Benefits & Side Effects
Observations are provided for general educational and research reference only.
  • Research Information: This section provides general research-related information for educational reference.
  • Research Reference: This content is not intended as medical advice, clinical guidance, or general usage information.
  • Research Details: For specific research details, please contact us on Telegram.
  • Availability: General availability information is available upon request.
  • Important: For additional information or support, please contact us on Telegram.
  • Lifestyle Factors

Complementary strategies for optimal outcomes.

  • Nutrition: Pair with a balanced, protein-forward diet tailored to individual energy and recovery needs.
  • Exercise: Combine resistance training and aerobic activity to support overall fitness and wellness goals.
  • Sleep: Prioritize 7–9 hours of quality sleep to support general recovery and consistency.rs of quality sleep to support general recovery and consistency.
  • Wellness: Manage stress and avoid chronic caloric restriction to support overall wellness.
  • Research Handling Information

General research handling information for educational and research reference only.

  • Handling Information: Please follow the provided label or packaging instructions for general handling information.
  • Research Details: For specific details, please contact us on Telegram.
  • Additional Information: For further information, please contact us directly.
  • Important: This content is not intended as medical advice, clinical guidance, research guidance, or general information.
  • More Information

For general research information, availability, or additional support, please contact us on Telegram.

Why Vitality Labs?

  • Research Details: General research information is available upon request.
  • Availability: For availability details, please contact us on Telegram.
  • Support: For additional research-related questions, please contact us directly.
Contact on Telegram
  • Important Note
This content is provided for general educational and research reference only and does not constitute medical advice, diagnosis, clinical guidance, research guidance, or general usage information.
  • References

Explore related research information and background reading for BPC-157 + TB-500.

Journal of Clinical Endocrinology & Metabolism

— Prolonged stimulation of GH and IGF-I secretion by CJC-1295 in healthy adults
More Info

European Journal of Endocrinology

— Ipamorelin, the first selective growth hormone secretagogue
More Info

Endocrine Reviews

— Growth hormone secretagogues: mechanisms and clinical applications
More Info

Annals of the New York Academy of Sciences (PubMed)

— Thymosin beta 4 and wound healing: new ideas
More Info

Sleep Medicine Reviews

— Sleep and the GH/IGF-1 axis: physiological and clinical implications
More Info

Bachem

— Handling and storage guidelines for peptides (lyophilized stability)
More Info

Bachem

— Reconstituted peptide storage and stability recommendations
More Info

Translational Andrology and Urology (PMC)

— GH secretagogues in body composition management for hypogonadal males
More Info

International Journal of Surgery (PubMed)

— Ipamorelin for postoperative ileus: tolerability and safety in bowel resection patients
More Info

NCBI Bookshelf

— Medication Information: research background and general educational overview
More Info

CDC

— Vaccine administration guidelines: subcutaneous route (no aspiration required)
More Info

Growth Hormone & IGF Research (ScienceDirect)

— Ipamorelin induces longitudinal bone growth in rats
More Info

Physiological Reviews

— The somatotropic axis: GH and IGF-1 regulation and actions
More Info

Clinical Drug Investigation (PMC)

— Subcutaneous drug delivery: pharmacokinetic considerations
More Info